Clinical development of Modified Vaccinia virus Ankara vaccines.

Clinical development of Modified Vaccinia virus Ankara vaccines.

Hiển thị phiên bản (1) khác

The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...

Mô tả đầy đủ

Chi tiết về thư mục
Tác giả chính:	Gilbert, S
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2013

Những quyển sách tương tự

Clinical development of Modified Vaccinia virus Ankara vaccines
Bằng: Gilbert, S
Được phát hành: (2013)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Bằng: Olga Vladimirovna Orlova, et al.
Được phát hành: (2022-09-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
Bằng: Gilbert, S, et al.
Được phát hành: (1999)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
Bằng: Kaïdre Bendjama, et al.
Được phát hành: (2017-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
Bằng: Volker Sandig, et al.
Được phát hành: (2013-11-01)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
Bằng: Juan García-Arriaza, et al.
Được phát hành: (2021-08-01)

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
Bằng: Alina Tscherne, et al.
Được phát hành: (2024-11-01)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Bằng: López-Camacho, C, et al.
Được phát hành: (2019)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Bằng: Alharbi, N
Được phát hành: (2014)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
Bằng: César López-Camacho, et al.
Được phát hành: (2019-11-01)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
Bằng: Caroline Staib, et al.
Được phát hành: (2003-04-01)

Ebola virus – prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
Bằng: Harriet L. Robinson, et al.
Được phát hành: (2018-09-01)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Bằng: McConkey, S, et al.
Được phát hành: (2003)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Bằng: Rosario, M, et al.
Được phát hành: (2010)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Bằng: Flavia Chiuppesi, et al.
Được phát hành: (2024-02-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
Bằng: Mingwang Shen, et al.
Được phát hành: (2024-10-01)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
Bằng: Alharbi, N, et al.
Được phát hành: (2015)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
Bằng: C. Staib, et al.
Được phát hành: (2000-06-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
Bằng: Malachy I. Okeke, et al.
Được phát hành: (2017-10-01)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.
Bằng: Naif Khalaf Alharbi, et al.
Được phát hành: (2015-01-01)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
Bằng: Schmidt, C, et al.
Được phát hành: (2008)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
Bằng: Behboudi, S, et al.
Được phát hành: (2004)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
Bằng: Schneider, J, et al.
Được phát hành: (1998)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
Bằng: Dorrell, L, et al.
Được phát hành: (2000)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
Bằng: Nereida Jiménez de Oya, et al.
Được phát hành: (2022-03-01)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
Bằng: Hanke, T, et al.
Được phát hành: (1998)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
Bằng: Cottingham, M, et al.
Được phát hành: (2008)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified <i>Vaccinia virus</i> Ankara (MVA)
Bằng: Maurilia Marcacci, et al.
Được phát hành: (2020-07-01)

Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant
Bằng: Ning Yang, et al.
Được phát hành: (2022-10-01)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
Bằng: Winslow, R, et al.
Được phát hành: (2017)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
Bằng: Matthew G Cottingham, et al.
Được phát hành: (2008-02-01)

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Bằng: David A Garber, et al.
Được phát hành: (2009-01-01)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
Bằng: Goepfert P, et al.
Được phát hành: (2012-09-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
Bằng: McConkey, S, et al.
Được phát hành: (2003)

Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model.
Bằng: Miriam Nörder, et al.
Được phát hành: (2010-01-01)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
Bằng: Mcshane, H, et al.
Được phát hành: (2001)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
Bằng: Hanke, T, et al.
Được phát hành: (2007)